Emcure Pharmaceuticals is launching Poviztra, a new version of Novo Nordisk’s GLP-1 weight management drug, in India. This move increases Emcure's role in the quickly growing market for obesity treatments
Bharat Biotech signs a tech transfer deal with Biofabri to develop and supply the MTBVAC tuberculosis vaccine, supporting global TB control and Phase III trials.
The Indian Pharmaceutical Alliance (IPA) has revealed $15 million expenditure to build a dedicated pharmaceutical quality institute in Ahmedabad.
Merck has revealed a historic deal with the American government meant to increase prescription drug access for American consumers while simultaneously lowering costs.
The Most Favoured Nation (MFN) drug pricing policy proposed in the United States is not expected to have an immediate impact on Indian pharmaceutical companies, according to industry analysts and market experts. The policy seeks to align US prescr...
Cipla partners with Pfizer to exclusively market five established brands in India, strengthening acute therapy presence and expanding patient access through a nationwide distribution network.
AstraZeneca Pharma India Ltd. (AZPIL) has received approval from the Central Drugs Standard Control Organisation (CDSCO) to import, sell, and distribute datopotamab deruxtecan (Dato-DXd) in India for the treatment of metastatic breast cance...
Senores Pharmaceuticals acquires Apnar Pharma in a move that strengthens its footprint across regulated global markets. The company has signed a definitive agreement to acquire a 100 percent equity stake in Apnar Pharma Private Limited, along...
Takeda’s experimental AI-crafted psoriasis pill, zasocitinib, achieved impressive results in two pivotal Phase?3 trials, marking a major milestone in the treatment of plaque psoriasis.Compared to placebo and active comparators, the once-per-day...
Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for travoprost ophthalmic solution USP, 0.004%. The product is indicated for the reductio...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")